The Ghana Health Service (GHS) has confirmed three cases of Mpox (formerly known as Monkeypox) in Ghana as of May 15, 2025.
All cases have been mild, with no reported deaths.
According to the GHS, the first case was identified in February, while the two most recent were detected earlier this month. The cases are unrelated.
The first patient is a 32-year-old male on antiretroviral therapy who reported a week-long history of fever, chills, and pustular lesions while the second is a 34-year-old male who experienced a generalized rash over two weeks that did not respond to self-medication.
GHS Director-General, Professor Samuel Kaba Akoriyea, assured the public that the situation is under control. “Ghana’s public health system remains vigilant. Established protocols for detection, management, and control of infectious diseases are being rigorously followed,” he stated.
The GHS has launched contact tracing and intensified surveillance nationwide to detect and manage any further suspected cases promptly.
The public is advised to practice good hand hygiene, avoid close contact with symptomatic individuals, and report any suspected cases to the nearest health facility.
Mpox is a viral illness related to smallpox, spreading through direct contact with infected skin or bodily fluids, including sexual contact. Symptoms include fever, rash or lesions, swollen lymph nodes, fatigue, headaches, and muscle pain.
Across Africa, Mpox remains a significant health concern. As of March 2025, over 24,200 cases and approximately 260 deaths have been reported in 22 countries, with the Democratic Republic of the Congo hardest hit.
Story By: Michael Abayatey
